Free shipping on all orders over $ 500

Levetiracetam

Cat. No. M2257

All AbMole products are for research use only, cannot be used for human consumption.

Levetiracetam Structure
Synonym:

Keppra; UCB L059

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mg USD 20  USD20 In stock
50mg USD 60  USD60 In stock
100mg USD 100  USD100 In stock
500mg USD 280  USD280 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Levetiracetam (UCB L059) is an antiepileptic, it is also a selective M2 muscarinic acetylcholine receptors (mAChR) inhibitor. Levetiracetam displays potent seizure protection in animal models of chronic epilepsy but lacks activity in acute seizure models. Levetiracetam binds synaptic vesicle protein 2A (SV2A).

Chemical Information
Molecular Weight 170.21
Formula C8H14N2O2
CAS Number 102767-28-2
Solubility (25°C) DMSO ≥ 30 mg/mL
Water ≥ 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Anthony Marson, et al. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

[2] Cynthia Sharpe, et al. Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial

[3] James M Chamberlain, et al. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial

[4] Mark D Lyttle, et al. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial

[5] Paul Howard, et al. Levetiracetam

Related AChR/AChE Products
AT 1001

AT 1001 is a high-affinity and selective antagonist of the α3β4 nicotinic acetylcholine receptor (α3β4 nAChR) with Ki of 2.64 nM.

Dihydro-β-erythroidine hydrobromide

Dihydro-β-erythroidine hydrobromide is a potent, orally active, and competitive antagonist of neuronal nAChRs. Dihydro-β-erythroidine hydrobromide shows selectivity for α4β4 and α4β2 nAChRs, with IC50s of 0.19 and 0.37 μM, respectively.

Spinosad

Spinosad, a mixture of spinosyns A and D known as fermentation products of a soil actinomycete (Saccharopolyspora spinosa), is a biological neurotoxic insecticide with a broader action spectrum. Spinosad targets the nicotinic acetylcholine receptor (nAChRs) of the insect nervous system.

TAE-1 

TAE-1 is a potent inhibitor of AChE and BuChE.

PE154 

PE154 is a potent fluorescent inhibitor of human acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) (IC50s=280 pM and 16 nM, respectively).

  Catalog
Abmole Inhibitor Catalog




Keywords: Levetiracetam, Keppra; UCB L059 supplier, AChR/AChE, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.